UNC Hospitals, University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 24514.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
UNC Hospitals, University of North Carolina at Chapel Hill has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation.
Sponsors: Uma Borate, Puma Biotechnology, Inc., Alice Mims.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Hospitals, University of North Carolina at Chapel Hill has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Hospitals, University of North Carolina at Chapel Hill has 5 clinical trials on record, with 4 currently active. Their work covers Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation.
UNC Hospitals, University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.